Clinical activity of abiraterone plus prednisone in docetaxel-naïve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer

This study investigated the clinical activity of abiraterone plus prednisone in docetaxel-naïve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer (mCRPC). A total of 146 patients with docetaxel-naïve group (103 cases) and docetaxel-resistant group (43 case...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Guo-Wen, Li, Gao-Xiang, Dai, Bo, Ye, Ding-Wei, Kong, Yun-Yi, Wang, Yue, Shen, Yi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413557/
https://www.ncbi.nlm.nih.gov/pubmed/30560837
http://dx.doi.org/10.4103/aja.aja_85_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413557/
https://www.ncbi.nlm.nih.gov/pubmed/30560837
http://dx.doi.org/10.4103/aja.aja_85_18

Ejemplares similares